Bio-Path
Bio-Path develops and commercializes DNA therapeutics for the treatment of acute myeloid leukemia and solid tumors.
Business Model:
Revenue: $37k
Employees: 2-10
Rankings
Industries / Tags:
Detailed Bio-Path Information
Geographic Data
Address: 4710 Bellaire Blvd
City: Bellaire
State: TX
Zip: 77401
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$2M
Raised Total:$10M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Bio-Path develops and commercializes DNA therapeutics for the treatment of acute myeloid leukemia and solid tumors.
Contact Phone:
+18327421357
Contact Email:
Bio-Path went public on 8/27/2012 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/27/2012
Ticker Symbol:
BPTH
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2010 | Post-IPO Equity | $741k | 5/2013 | Post-IPO Equity | $453k | 3/2019 | Post-IPO Equity | $19.6M | 6/2010 | Post-IPO Equity | $923k | 2/2021 | Post-IPO Equity | $13M | 1/2019 | Unattributed | $987.7k | 11/2022 | Post-IPO Equity | $2M | 3/2019 | Unattributed | $1.4M | 1/2019 | Equity | $83.8k | 9/2018 | Unattributed | $2.3M | 11/2019 | Post-IPO Equity | $8M | 1/2019 | Post-IPO Equity | $1.7M | 9/2018 | Post-IPO Equity | $1.5M | 6/2010 | Post-IPO Equity | $200k |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
